The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Exosomes-Global Market Insights and Sales Trends 2024
Synopsis
The global Exosomes market size is expected to reach US$ 1166.7 million by 2029, growing at a CAGR of 16.1% from 2023 to 2029. The market is mainly driven by the significant applications of Exosomes in various end use industries. The expanding demands from the Cancer, Infectious diseases, Neurodegenerative diseases and Cardiovascular diseases, are propelling Exosomes market. Non-coding RNAs, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Lipids segment is estimated at % CAGR for the next seven-year period.
Asia Pacific shows high growth potential for Exosomes market, driven by demand from China, the second largest economy with some signs of stabilising, the Exosomes market in China is forecast to reach US$ million by 2029, trailing a CAGR of % over the 2023-2029 period, while the U.S. market will reach US$ million by 2029, exhibiting a CAGR of % during the same period.
Report Objectives
This report provides market insight on the different segments, by players, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Exosomes, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Exosomes market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Exosomes market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Exosomes sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Exosomes covered in this report include Fujifilm, Thermo Fisher Scientific, Danaher, Illumina, Qiagen, Takara Bio, Malvern Instruments, Miltenyi Biotec and MBL International, etc.
The global Exosomes market report caters to various stakeholders in this industry including investors, suppliers, product players, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
Fujifilm
Thermo Fisher Scientific
Danaher
Illumina
Qiagen
Takara Bio
Malvern Instruments
Miltenyi Biotec
MBL International
Lonza
Global Exosomes market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Exosomes market, Segment by Type:
Non-coding RNAs
Lipids
mRNA
DNA fragments
Proteins /peptides
Global Exosomes market, by Application
Cancer
Infectious diseases
Neurodegenerative diseases
Cardiovascular diseases
Core Chapters
Chapter One: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2018-2023, 2024-2029). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter Two: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter Three: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter Four: Detailed analysis of Exosomes companies’ competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Five: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.
Chapter Six, Seven, Eight, Nine and Ten: North America, Europe, Asia Pacific, Latin America, Middle East & Africa, revenue by country.
Chapter Eleven: this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Research Finding/Conclusion
The global Exosomes market size is expected to reach US$ 1166.7 million by 2029, growing at a CAGR of 16.1% from 2023 to 2029. The market is mainly driven by the significant applications of Exosomes in various end use industries. The expanding demands from the Cancer, Infectious diseases, Neurodegenerative diseases and Cardiovascular diseases, are propelling Exosomes market. Non-coding RNAs, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Lipids segment is estimated at % CAGR for the next seven-year period.
Asia Pacific shows high growth potential for Exosomes market, driven by demand from China, the second largest economy with some signs of stabilising, the Exosomes market in China is forecast to reach US$ million by 2029, trailing a CAGR of % over the 2023-2029 period, while the U.S. market will reach US$ million by 2029, exhibiting a CAGR of % during the same period.
Report Objectives
This report provides market insight on the different segments, by players, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Exosomes, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Exosomes market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Exosomes market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Exosomes sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Exosomes covered in this report include Fujifilm, Thermo Fisher Scientific, Danaher, Illumina, Qiagen, Takara Bio, Malvern Instruments, Miltenyi Biotec and MBL International, etc.
The global Exosomes market report caters to various stakeholders in this industry including investors, suppliers, product players, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
Fujifilm
Thermo Fisher Scientific
Danaher
Illumina
Qiagen
Takara Bio
Malvern Instruments
Miltenyi Biotec
MBL International
Lonza
Global Exosomes market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Exosomes market, Segment by Type:
Non-coding RNAs
Lipids
mRNA
DNA fragments
Proteins /peptides
Global Exosomes market, by Application
Cancer
Infectious diseases
Neurodegenerative diseases
Cardiovascular diseases
Core Chapters
Chapter One: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2018-2023, 2024-2029). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter Two: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter Three: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter Four: Detailed analysis of Exosomes companies’ competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Five: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.
Chapter Six, Seven, Eight, Nine and Ten: North America, Europe, Asia Pacific, Latin America, Middle East & Africa, revenue by country.
Chapter Eleven: this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Research Finding/Conclusion
Index1 Market Overview of Exosomes
1.1 Exosomes Market Overview
1.1.1 Exosomes Product Scope
1.1.2 Exosomes Market Status and Outlook
1.2 Global Exosomes Market Size Overview by Region 2018 VS 2022 VS 2029
1.3 Global Exosomes Market Size by Region (2018-2029)
1.4 Global Exosomes Historic Market Size by Region (2018-2023)
1.5 Global Exosomes Market Size Forecast by Region (2024-2029)
1.6 Key Regions, Exosomes Market Size (2018-2029)
1.6.1 North America Exosomes Market Size (2018-2029)
1.6.2 Europe Exosomes Market Size (2018-2029)
1.6.3 Asia-Pacific Exosomes Market Size (2018-2029)
1.6.4 Latin America Exosomes Market Size (2018-2029)
1.6.5 Middle East & Africa Exosomes Market Size (2018-2029)
2 Exosomes Market by Type
2.1 Introduction
2.1.1 Non-coding RNAs
2.1.2 Lipids
2.1.3 mRNA
2.1.4 DNA fragments
2.1.5 Proteins /peptides
2.2 Global Exosomes Market Size by Type: 2018 VS 2022 VS 2029
2.2.1 Global Exosomes Historic Market Size by Type (2018-2023)
2.2.2 Global Exosomes Forecasted Market Size by Type (2024-2029)
2.3 Key Regions Market Size by Type
2.3.1 North America Exosomes Revenue Breakdown by Type (2018-2029)
2.3.2 Europe Exosomes Revenue Breakdown by Type (2018-2029)
2.3.3 Asia-Pacific Exosomes Revenue Breakdown by Type (2018-2029)
2.3.4 Latin America Exosomes Revenue Breakdown by Type (2018-2029)
2.3.5 Middle East and Africa Exosomes Revenue Breakdown by Type (2018-2029)
3 Exosomes Market Overview by Application
3.1 Introduction
3.1.1 Cancer
3.1.2 Infectious diseases
3.1.3 Neurodegenerative diseases
3.1.4 Cardiovascular diseases
3.2 Global Exosomes Market Size by Application: 2018 VS 2022 VS 2029
3.2.1 Global Exosomes Historic Market Size by Application (2018-2023)
3.2.2 Global Exosomes Forecasted Market Size by Application (2024-2029)
3.3 Key Regions Market Size by Application
3.3.1 North America Exosomes Revenue Breakdown by Application (2018-2029)
3.3.2 Europe Exosomes Revenue Breakdown by Application (2018-2029)
3.3.3 Asia-Pacific Exosomes Revenue Breakdown by Application (2018-2029)
3.3.4 Latin America Exosomes Revenue Breakdown by Application (2018-2029)
3.3.5 Middle East and Africa Exosomes Revenue Breakdown by Application (2018-2029)
4 Exosomes Competition Analysis by Players
4.1 Global Exosomes Market Size by Players (2018-2023)
4.2 Global Top Players by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Exosomes as of 2022)
4.3 Date of Key Players Enter into Exosomes Market
4.4 Global Top Players Exosomes Headquarters and Area Served
4.5 Key Players Exosomes Product Solution and Service
4.6 Competitive Status
4.6.1 Exosomes Market Concentration Rate
4.6.2 Mergers & Acquisitions, Expansion Plans
5 Company (Top Players) Profiles
5.1 Fujifilm
5.1.1 Fujifilm Profile
5.1.2 Fujifilm Main Business
5.1.3 Fujifilm Exosomes Products, Services and Solutions
5.1.4 Fujifilm Exosomes Revenue (US$ Million) & (2018-2023)
5.1.5 Fujifilm Recent Developments
5.2 Thermo Fisher Scientific
5.2.1 Thermo Fisher Scientific Profile
5.2.2 Thermo Fisher Scientific Main Business
5.2.3 Thermo Fisher Scientific Exosomes Products, Services and Solutions
5.2.4 Thermo Fisher Scientific Exosomes Revenue (US$ Million) & (2018-2023)
5.2.5 Thermo Fisher Scientific Recent Developments
5.3 Danaher
5.3.1 Danaher Profile
5.3.2 Danaher Main Business
5.3.3 Danaher Exosomes Products, Services and Solutions
5.3.4 Danaher Exosomes Revenue (US$ Million) & (2018-2023)
5.3.5 Illumina Recent Developments
5.4 Illumina
5.4.1 Illumina Profile
5.4.2 Illumina Main Business
5.4.3 Illumina Exosomes Products, Services and Solutions
5.4.4 Illumina Exosomes Revenue (US$ Million) & (2018-2023)
5.4.5 Illumina Recent Developments
5.5 Qiagen
5.5.1 Qiagen Profile
5.5.2 Qiagen Main Business
5.5.3 Qiagen Exosomes Products, Services and Solutions
5.5.4 Qiagen Exosomes Revenue (US$ Million) & (2018-2023)
5.5.5 Qiagen Recent Developments
5.6 Takara Bio
5.6.1 Takara Bio Profile
5.6.2 Takara Bio Main Business
5.6.3 Takara Bio Exosomes Products, Services and Solutions
5.6.4 Takara Bio Exosomes Revenue (US$ Million) & (2018-2023)
5.6.5 Takara Bio Recent Developments
5.7 Malvern Instruments
5.7.1 Malvern Instruments Profile
5.7.2 Malvern Instruments Main Business
5.7.3 Malvern Instruments Exosomes Products, Services and Solutions
5.7.4 Malvern Instruments Exosomes Revenue (US$ Million) & (2018-2023)
5.7.5 Malvern Instruments Recent Developments
5.8 Miltenyi Biotec
5.8.1 Miltenyi Biotec Profile
5.8.2 Miltenyi Biotec Main Business
5.8.3 Miltenyi Biotec Exosomes Products, Services and Solutions
5.8.4 Miltenyi Biotec Exosomes Revenue (US$ Million) & (2018-2023)
5.8.5 Miltenyi Biotec Recent Developments
5.9 MBL International
5.9.1 MBL International Profile
5.9.2 MBL International Main Business
5.9.3 MBL International Exosomes Products, Services and Solutions
5.9.4 MBL International Exosomes Revenue (US$ Million) & (2018-2023)
5.9.5 MBL International Recent Developments
5.10 Lonza
5.10.1 Lonza Profile
5.10.2 Lonza Main Business
5.10.3 Lonza Exosomes Products, Services and Solutions
5.10.4 Lonza Exosomes Revenue (US$ Million) & (2018-2023)
5.10.5 Lonza Recent Developments
6 North America
6.1 North America Exosomes Market Size by Country (2018-2029)
6.2 U.S.
6.3 Canada
7 Europe
7.1 Europe Exosomes Market Size by Country (2018-2029)
7.2 Germany
7.3 France
7.4 U.K.
7.5 Italy
7.6 Russia
7.7 Nordic Countries
7.8 Rest of Europe
8 Asia-Pacific
8.1 Asia-Pacific Exosomes Market Size by Region (2018-2029)
8.2 China
8.3 Japan
8.4 South Korea
8.5 Southeast Asia
8.6 India
8.7 Australia
8.8 Rest of Asia-Pacific
9 Latin America
9.1 Latin America Exosomes Market Size by Country (2018-2029)
9.2 Mexico
9.3 Brazil
9.4 Rest of Latin America
10 Middle East & Africa
10.1 Middle East & Africa Exosomes Market Size by Country (2018-2029)
10.2 Turkey
10.3 Saudi Arabia
10.4 UAE
10.5 Rest of Middle East & Africa
11 Exosomes Market Dynamics
11.1 Exosomes Industry Trends
11.2 Exosomes Market Drivers
11.3 Exosomes Market Challenges
11.4 Exosomes Market Restraints
12 Research Finding /Conclusion
13 Methodology and Data Source
13.1 Methodology/Research Approach
13.1.1 Research Programs/Design
13.1.2 Market Size Estimation
13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
13.2.1 Secondary Sources
13.2.2 Primary Sources
13.3 Disclaimer
13.4 Author List
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
